Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Informed Consent

May 15, 2019 (Noon–1 p.m. ET)

Sponsor/Co-Sponsor(s)

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act, NICHD  

Location

Webinar

Purpose

For this webinar, Donna L. Snyder, M.D., will cover the foundations and mandatory and optional elements of informed consent. She also will discuss the obtaining of consent/assent from vulnerable subjects, reasonably foreseeable risks, and the regulations governing informed consent.

Dr. Snyder is a pediatric ethicist and team lead in the Office of Pediatric Therapeutics in the Office of the Commissioner at the U.S. Food and Drug Administration.

Contact

George Giacoia, OPPTB, NICHD
Phone: 301–496–5589
Email: giacoiag@mail.nih.gov

 
Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of page BACK TO TOP